Evidence map›Paper›PMID 35387836›Full record

ArticleBMJ open2022

Dynamics, outcomes and prerequisites of the first SARS-CoV-2 superspreading event in Germany in February 2020: a cross-sectional epidemiological study.

Lukas Wessendorf, Enrico Richter, Bianca Schulte, Ricarda Maria Schmithausen, Martin Exner, Nils Lehmann, Martin Coenen, Christine Fuhrmann, Angelika Kellings, Anika Hüsing and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Non-pharmaceutical interventions for COVID-19: a systematic review on environmental control measures.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reconstruction of the origin of the first major SARS-CoV-2 outbreak in Germany.Computational and structural biotechnology journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lukas WessendorfInstitute of Virology, University Hospital Bonn, Bonn, Germany.
Enrico RichterInstitute of Virology, University Hospital Bonn, Bonn, Germany.
Bianca SchulteInstitute of Virology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-1096-3751
Ricarda Maria SchmithausenDepartment of Hygiene, University Hospital Bonn, Bonn, Germany.
Martin ExnerDepartment of Hygiene, University Hospital Bonn, Bonn, Germany.
Nils LehmannInstitute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Duisburg, Germany.
Martin CoenenClinical Study Core Unit, Study Center Bonn (SZB), Rheinische Friedrich Wilhelms Universitat Bonn, Bonn, Germany.
Christine FuhrmannClinical Study Core Unit, Study Center Bonn (SZB), Rheinische Friedrich Wilhelms Universitat Bonn, Bonn, Germany.
Angelika KellingsClinical Study Core Unit, Study Center Bonn (SZB), Rheinische Friedrich Wilhelms Universitat Bonn, Bonn, Germany.
Anika HüsingInstitute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Duisburg, Germany.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Duisburg, Germany.
Hendrik StreeckInstitute of Virology, University Hospital Bonn, Bonn, Germany Streeck@ukbonn.de.
University Hospital Bonn · DEUniversity of Bonn · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe first German SARS-CoV-2 outbreak was a superspreading event in Gangelt, North Rhine-Westphalia, during indoor carnival festivities called 'Kappensitzung' (15 February 2020). We determined SARS-CoV-2 RT-PCR positivity rate, SARS-CoV-2-specific antibodies, and analysed the conditions and dynamics of superspreading, including ventilation, setting dimensions, distance from infected persons and behavioural patterns.

designIn a cross-sectional epidemiological study (51 days postevent), participants were asked to give blood, pharyngeal swabs and complete self-administered questionnaires.

settingThe SARS-CoV-2 superspreading event took place during festivities in the small community of Gangelt in February 2020. This 5-hour event included 450 people (6-79 years of age) in a building of 27 m × 13.20 m × 4.20 m.

participantsOut of 450 event participants, 411 volunteered to participate in this study. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome: infection status (determined by IgG ELISA). SECONDARY OUTCOME: symptoms (determined by questionnaire).

resultsOverall, 46% (n=186/404) of participants had been infected, and their spatial distribution was associated with proximity to the ventilation system (OR 1.39, 95% CI 0.86 to 2.25). Risk of infection was highly associated with age: children (OR 0.33, 95% CI 0.267 to 0.414) and young adults (age 18-25 years) had a lower risk of infection than older participants (average risk increase of 28% per 10 years). Behavioural differences were also risk associated including time spent outside (OR 0.55, (95% CI 0.33 to 0.91) or smoking (OR 0.32, 95% CI 0.124 to 0.81).

conclusionsOur findings underline the importance of proper indoor ventilation for future events. Lower susceptibility of children/young adults indicates their limited involvement in superspreading.

Indexed as

COVID-19SARS-CoV-2AdolescentAdultAntibodies, ViralChildCross-Sectional StudiesDisease OutbreaksGermanyHumansInfantYoung AdultAntibodies, ViralCOVID-19Infection controlVIROLOGY

Identifiers

PMID35387836
PMCPMC8987213
OpenAlexW4223465775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.